JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dogrul, A.
Right arrow Articles by Uzbay, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dogrul, A.
Right arrow Articles by Uzbay, T.

Anesth Analg 2006;103:471-477
© 2006 International Anesthesia Research Society
doi: 10.1213/01.ane.0000223680.54063.f6


PAIN MEDICINE

The Contribution of Alpha-1 and Alpha-2 Adrenoceptors in Peripheral Imidazoline and Adrenoceptor Agonist-Induced Nociception

Ahmet Dogrul, MD, Ilke Coskun, and Tayfun Uzbay

From the Gülhane Military Medical Academy, Faculty of Medicine, Department of Medical Pharmacology, Psychopharmacology Research Unit, Ankara, Turkey.

Address correspondence and reprint requests to Ahmet Dogrul, MD, Gülhane Military Medical Academy, Faculty of Medicine, Department of Medical Pharmacology, Ankara, Turkey. Address e-mail to dogrula{at}gata.edu.tr.

We evaluated the effects of activation of peripheral adrenoceptors (AR) and imidazoline receptors on nociception and the contribution of {alpha}-1 and {alpha}-2 AR receptors in agonist-induced nociception by using the tail-flick test in mice. Clonidine ({alpha}-2 AR agonist), agmatine (imidazoline receptor and {alpha}-2 AR agonist), noradrenaline (mixed {alpha}-1 and {alpha}-2 AR agonist), phenylephrine ({alpha}-1 AR agonist), or 0.9% saline was given by intradermal injection (10 µL) into the tail. The intradermal injection of clonidine (1, 3, and 10 µg) and agmatine (3, 30, and 50 µg) produced dose-dependent antinociception, whereas noradrenaline (1, 10, and 30 µg) and phenylephrine (1, 10 and 30 µg) produced dose-dependent thermal hyperalgesia. Clonidine (10 µg) and agmatine (50 µg)-induced peripheral antinociception were antagonized by pretreatment with yohimbine (2.5 mg/kg IP), a selective {alpha}-2 AR antagonist, but not by prazosin (1 mg/kg IP), a selective {alpha}-1 AR antagonist. Noradrenaline (30 µg) and phenylephrine (30 µg)-induced thermal hyperalgesia were antagonized by prazosin (1 mg/kg IP) but not by yohimbine (2.5 mg/kg IP). Our results suggest that local thermal hyperalgesic effects of noradrenaline and phenylephrine are linked to {alpha}-1 AR and the peripheral antinociceptive action of clonidine and agmatine are linked to {alpha}-2 AR.







Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2006 by the International Anesthesia Research Society.